GlaxoSmithKline Pharmaceuticals Limited — Others, 13-05-2025: Change in Director(s)

GlaxoSmithKline Pharmaceuticals Limited has announced a board meeting on its financial results for the quarter and year ended March 31, 2025. Standalone revenue stood at Rs. 966.08 Cr, with consolidated revenue at Rs. 974.37 Cr for the quarter. Profit after tax was Rs. 260.14 Cr (standalone) and Rs. 262.87 Cr (consolidated). A final dividend of Rs. 42 per share was declared. Dr. Sunita Maheshwari was re-appointed as an Independent Director for a second term, and Parikh & Associates have been appointed as Secretarial Auditors for five years starting FY 2025-26. Deloitte issued a clean audit opinion, confirming robust financial health.